M. R. HARNDEN
- Co-authors
- Richard L. JarvestM R BoydDavid SuttonR. Anthony Vere HodgeAmy ParkinPaul G. WyattStuart BaileyD. N. Planterose
- Topics
- HIV/AIDS drug development and treatment (12 papers)Synthesis and Characterization of Heterocyclic Compounds (11 papers)Cytomegalovirus and herpesvirus research (9 papers)
- Journals
- Journal of Medicinal ChemistryAntimicrobial Agents and ChemotherapyCellular and Molecular Life Sciences
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
M. R. HARNDEN
26 papers receiving 322 citations
Peers
Comparison fields: 5 of 58
- Epidemiology 197
- Organic Chemistry 139
- Infectious Diseases 124
- Molecular Biology 117
- Oncology 45
Countries citing papers authored by M. R. HARNDEN
This map shows the geographic impact of M. R. HARNDEN's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. R. HARNDEN with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. R. HARNDEN more than expected).
Fields of papers citing papers by M. R. HARNDEN
This network shows the impact of papers produced by M. R. HARNDEN. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. R. HARNDEN. The network helps show where M. R. HARNDEN may publish in the future.
Co-authorship network of co-authors of M. R. HARNDEN
This figure shows the co-authorship network connecting the top 25 collaborators of M. R. HARNDEN. A scholar is included among the top collaborators of M. R. HARNDEN based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. R. HARNDEN. M. R. HARNDEN is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 30 | |
| 3 | 1 | |
| 4 | C nucleoside studies part 21 synthesis of some hydroxyalkylated pyrrolo 3 2 d pyrimidines and thieno 3 2 d pyrimidines related to known antiviral acyclonucleosides | 18 |
| 5 | 10 | |
| 6 | 2 | |
| 7 | 9 | |
| 8 | 10 | |
| 9 | 158 | |
| 10 | 8 | |
| 11 | 9 | |
| 12 | 15 | |
| 13 | 1 | |
| 14 | 3 | |
| 15 | 46 | |
| 16 | 5 | |
| 17 | 1 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 5 |
About M. R. HARNDEN
M. R. HARNDEN is a scholar working on Organic Chemistry, Infectious Diseases and Pharmaceutical Science, having authored 29 papers that have together received 390 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (12 papers), Synthesis and Characterization of Heterocyclic Compounds (11 papers) and Cytomegalovirus and herpesvirus research (9 papers). The work is most often cited by research in Virology (37 citations), Infectious Diseases (124 citations) and Epidemiology (197 citations). M. R. HARNDEN has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Richard L. Jarvest, M R Boyd, David Sutton, R. Anthony Vere Hodge, Amy Parkin, Paul G. Wyatt, Stuart Bailey, D. N. Planterose, D. Malcolm Duckworth and Robert M. Perkins. Their work appears in journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.